HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Primary Peritoneal Cancer

Primary peritoneal cancer is a rare and aggressive form of cancer that develops in the peritoneum, the thin layer of tissue lining the abdomen and covering the organs within it. This type of cancer is closely related to epithelial ovarian cancer and often presents with similar symptoms. The peritoneum plays a crucial role in supporting and protecting abdominal organs, and when cancer originates in this tissue, it can rapidly spread to neighboring organs and tissues. The exact cause of primary peritoneal cancer is not well understood, but it is believed to be linked to genetic factors and mutations. Symptoms of primary peritoneal cancer may include abdominal pain or discomfort, bloating, changes in bowel habits, and unexplained weight loss. However, these symptoms are non-specific and can be associated with various other conditions, making early detection challenging. Diagnosis typically involves a combination of imaging tests, such as CT scans and ultrasounds, along with biopsies to confirm the presence of cancer cells. Treatment options often include a combination of surgery, chemotherapy, and sometimes radiation therapy. Due to the aggressive nature of primary peritoneal cancer, a multidisciplinary approach involving oncologists, surgeons, and other healthcare professionals is crucial in managing the disease. Prognosis for primary peritoneal cancer varies, and it depends on factors such as the stage at which the cancer is diagnosed and the individual's overall health. Early detection and prompt intervention can significantly improve outcomes, but the disease is often diagnosed in advanced stages, making successful treatment more challenging. Supportive care, including palliative measures to manage symptoms and enhance the quality of life, is an essential aspect of primary peritoneal cancer management. Patients and their families benefit from a comprehensive support system, including counseling, pain management, and resources for coping with the emotional and physical challenges associated with the disease.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp